Skip to main content

Table 3 Synovial fluid analysis

From: Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis – a prospective cohort study

Analysis

All (n = 105)

Responders (n = 61)

Non-responders (n = 44)

P-value

sf-TNF (pg/mL)

42 (0 to 1,128)

51 (0 to 1,128)

36 (0 to 182)

0.706

sf-IL6 (pg/mL)

734 (0 to 10,000)

636 (0 to 10,000)

1,062 (0 to 10,000)

0.625

sf-VEGF (pg/mL)

778 (128 to 2,518)

622 (128 to 2.518)

998 (282 to 1,926)

0.002

sf-MMP3 (pg/mL)

5,367 (64 to 143,896)

6,696 (64 to 143,896)

5189 (524 to 72,922)

0.686

sf-COMP (U/L)

58.5 ± 36.0

54.4 ± 27.1

63.6 ± 44.6

0.220

sf-Mono (x109/L)

1.7 (0 to 132.6)

1.9 (0 to 132.6)

1.5 (0 to 7.1)

0.208

sf-Poly (x109/L)

1.65 (0 to 32.1)

1.6 (0 to 19.5)

1.7 (0 to 32.1)

0.801

  1. Median (range), mean ± SD, Bold figures: P <0.003. COMP, cartilage oligomeric matrix protein; MMP3, matrix metalloproteinase 3; SD, standard deviation; sf, synovial fluid; VEGF, vascular endothelial growth factor.